Shockwave Medical
  • Technology
    • Challenges of Calcium
    • Intravascular Lithotripsy (IVL)
    • IVL Mechanism of Action
  • Clinicians
    • USA
    • Peripheral
      reimbursement Peripheral Reimbursement
      • Pre-TAVI
      • Pre-EVAR
      • Iliac
      • Common Femoral
      • Femoropopliteal
      • Infrapopliteal
      • Clinical Evidence
        • PAD I
        • PAD II
        • PAD III
        • BTK
      • PAD Case Library
      • Product Specs & Resources
        • Shockwave M5
    • reimbursement Peripheral Reimbursement
    • Coronary
      reimbursement Coronary Reimbursement
    • reimbursement Coronary Reimbursement
    • Transfemoral Access
      • Pre-TAVR
      • Pre-EVAR/TEVAR
    • International
    • Peripheral
      • Pre-TAVR
      • Pre-EVAR
      • Iliac
      • Common Femoral
      • Femoropopliteal
      • Infrapopliteal
      • Clinical Evidence
        • PAD I
        • PAD II
        • PAD III
        • BTK
      • PAD Case Library
      • Product Specs & Resources
        • Shockwave M5
    • Coronary
      • CAD Case Library
      • Clinical Evidence
        • CAD I
        • CAD II
        • CAD III
      • Product Specs & Resources
        • Shockwave C2
    • Transfemoral Access
      • Pre-TAVI
      • Pre-EVAR/TEVAR
  • Education
    • Calcium IVLeague
    • The Catalyst
  • Resources
    • IFU Portal
    • Peripheral Reimbursement
    • Coronary IVL Reimbursement
  • Investors
    • Overview
    • Stock Information
    • News & Events
    • Financial Information
    • Corporate Governance
    • Investor Resources
  • About
    • Our Story
    • People
    • Careers
    • Patents
    • Press Releases
    • Contact
Home Education Blog
catalyst_logo

Welcome to The Catalyst

Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.

ico email Connect
Topic: Shockwave Breaking News

Equality: Coronary IVL Outcomes by Sex

In episode #9 of the ChalkTalk podcast, we speak with Alexandra Lansky, MD, FACC, FAHA, FSCAI,...

Read More

SCAI 2022: New Practice-Changing IVL Data

In a few weeks, we are headed to a city known for its sunshine and southern hospitality, Atlanta,...

Read More

Turns Out the UK is Our Cup of Tea!

Shockwave is in the midst of preparing to go direct in the UK on 1st of July.

Read More
Topics
  • CAD Applications - Bifurcations
  • CAD Applications - Eccentric Lesions
  • Calcium Corner
  • ChalkTalk Podcast
  • Clinical Corner with Dr. Keith Dawkins
  • Clinical Corner with SW
  • Coronary Cases
  • Coronary Clinical Data
  • Coronary Conferences
  • Coronary IVL
  • Coronary IVL - U.S.
  • DISRUPT CAD
  • DISRUPT PAD
  • Insider
  • IVL Case
  • IVL Technology
  • Medical Meetings
  • PAD Applications - BTK
  • PAD Applications - CLI
  • PAD Applications - EVAR
  • PAD Applications - Iliac
  • PAD Applications - TAVR Access
  • PAD Applications - TEVAR
  • Peripheral Cases
  • Peripheral Clinical Data
  • Peripheral Conferences
  • Peripheral IVL
  • PulsePoint Newsletter
  • Q&A with Uday
  • Shockwave Behind-the-Scenes
  • Shockwave Breaking News
  • Shockwave C2
  • Shockwave M5
  • Shockwave S4
  • ShockwaveM5+
  • SWAV News

Equality: Coronary IVL Outcomes by Sex

Posted by Michelle Revell on May 18, 2022 4:00:00 PM
  • Tweet

In episode #9 of the ChalkTalk podcast, we speak with Alexandra Lansky, MD, FACC, FAHA, FSCAI, FESC, Professor of Medicine in Cardiology, and Director of Yale Cardiovascular Clinical Research Program at Yale University School of Medicine in New Haven, Connecticut, about her recent gender analyses at TCT21 and SCAI22, in which she presented the respective 30-day and 1-year outcomes broken out by women vs men that were enrolled in the Disrupt CAD clinical program.

 

Dr. Lansky shares the genesis of the analysis - previous research showing that female atherectomy patients have an increased risk for angiographic complications than their male counterparts,[i] and sheds light on what makes coronary IVL unique from a safety perspective. She concludes by discussing the recent publication of SCAI’s “Expert Consensus Statement on Sex-Specific Consideration in Myocardial Revascularization” in JSCAI, which referenced the role of IVL in female patients. The SCAI guidelines concluded, “while additional evidence is needed, these results taken in the context of outcomes with atherectomy devices suggest that IVL may emerge as a first-line therapy for plaque modification of calcified lesions in women specifically.”

 

We hope you enjoy the episode and for more information on coronary IVL in women, please visit TimeForAnIntervention.com.

 

 

 

[i] https://onlinelibrary.wiley.com/doi/10.1002/ccd.28373

Read More
0 Comments Click here to read/write comments

Topics: Shockwave Behind-the-Scenes, Coronary IVL, Shockwave Breaking News, IVL Technology, Coronary Cases, Coronary Clinical Data, Shockwave C2, Coronary Conferences, Coronary IVL - U.S., ChalkTalk Podcast

SCAI 2022: New Practice-Changing IVL Data

Posted by Michelle Revell on May 3, 2022 5:28:59 PM
  • Tweet

In a few weeks, we are headed to a city known for its sunshine and southern hospitality, Atlanta, Georgia, where SCAI 2022 is taking place this year. At the conference, leading calcium experts will share the 1-year results from the Randomized Disrupt PAD III Trial and 1-year sex specific outcomes with Coronary IVL. 

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, IVL Case, Peripheral IVL, Shockwave Breaking News, IVL Technology, DISRUPT PAD, Coronary Cases, Peripheral Cases, PAD Applications - BTK, Peripheral Conferences, SWAV News, Shockwave C2, Coronary Conferences, Shockwave M5, Shockwave S4, PAD Applications - TEVAR, Coronary IVL - U.S., ShockwaveM5+

Turns Out the UK is Our Cup of Tea!

Posted by Emma Miller on Apr 19, 2021 11:10:04 AM
  • Tweet

Shockwave is in the midst of preparing to go direct in the UK on 1st of July.

Read More
0 Comments Click here to read/write comments

Topics: Insider, Shockwave Breaking News, IVL Technology

All posts

We're excited about IVL's potential in aortic stenosis, too!

But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.

MORE ON TAVR ENABLING TRANSFEMORAL ACCESS
SIGN UP FOR UPDATES ON OUR VALVE R&D PROGRAM

Get Crackin with Shockwave IVL Today

To keep you apprised of the latest IVL news, education, and cases, please share your selected interests.

Shockwave Medical

Corporate Headquarters
5403 Betsy Ross Drive
Santa Clara, CA 95054
United States

1-877-77-LITHO (775-4846)

info@shockwavemedical.com

  • Technology
    • Challenges of Calcium
  • Applications
    • US
    • Peripheral
    • Coronary
    • TF Access
    • International
    • Peripheral
    • Coronary
    • TF Access
  • Education
    • Ca++ IVLeague
    • The Catalyst
  • Resources
    • IFU Portal
    • Peripheral Reimbursement
    • Coronary Reimbursement
  • Investors
  • About Us
    • Our Story
    • People
    • Careers
    • Patents
    • Press Releases
    • Contact
Follow us

Prior to use, please reference the Instructions for Use for more information on indications, contraindications, warnings, precautions and adverse events.

  • Privacy Policy
  • ISI
  • Patents

© 2022 Shockwave Medical Inc. All rights reserved. | SPL 63081 Rev. A